AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7876651 — intervention group
Group type: EXPERIMENTAL
Intervention: One injection on day 0 and 30
Number of subjects: 276
Study 7876651 — intervention group
Group type: EXPERIMENTAL
Intervention: One injection on day 0 and 180
Number of subjects: 276
Study 7876651 — intervention group
Group type: EXPERIMENTAL
Intervention: Third dose on day 380
Number of subjects: 276
Study 2197845 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous infusion of 400 micrograms octreotide per day
Number of subjects: 20
Study 2197845 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 20
Study 881256 — intervention group
Group type: EXPERIMENTAL
Intervention: Proplast-coated Thompson prosthesis
Number of subjects: 20
Study 881256 — intervention group
Group type: COMPARATOR
Intervention: Cemented Thompson prosthesis
Number of subjects: 20
Study 31129874 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive and interceptive orthodontic treatment needs (P&I Tx need) as assessed by the Index for Preventive and Interceptive Orthodontic Needs (IPION)
Number of subjects: 202
Study 31129874 — intervention group
Group type: EXPERIMENTAL
Intervention: Characteristics associated with P&I Tx need
Number of subjects: 202
Study 31129874 — intervention group
Group type: EXPERIMENTAL
Intervention: IPION scores in the definite treatment need group
Number of subjects: 202
Study 27554812 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily pasteurized raw whole egg powder
Number of subjects: 820
Study 27554812 — intervention group
Group type: COMPARATOR
Intervention: Color-matched rice powder (control)
Number of subjects: 820
Study 25772960 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous iron sucrose (divided doses)
Number of subjects: 0
Study 25772960 — intervention group
Group type: EXPERIMENTAL
Intervention: Total daily intake of Low Molecular Weight (LMW) iron dextran
Number of subjects: 0
Study 24012983 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspiration therapy plus lifestyle therapy (n=11)
Number of subjects: 18
Study 24012983 — intervention group
Group type: COMPARATOR
Intervention: Lifestyle therapy only (n=7)
Number of subjects: 18
Study 24012983 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspiration therapy (n=10 who completed additional year)
Number of subjects: 18
Study 21248213 — intervention group
Group type: EXPERIMENTAL
Intervention: Locking intramedullary nail
Number of subjects: 51
Study 21248213 — intervention group
Group type: COMPARATOR
Intervention: Locking plate
Number of subjects: 51
Study 18957269 — intervention group
Group type: COMPARATOR
Intervention: Tension-free vaginal tape (TVT)
Number of subjects: 315
Study 18957269 — intervention group
Group type: EXPERIMENTAL
Intervention: Inside-out transobturator tape (TVT-O)
Number of subjects: 315
Study 17296184 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided embryo transfer
Number of subjects: 50
Study 17296184 — intervention group
Group type: COMPARATOR
Intervention: Clinical touch transfers
Number of subjects: 50
Study 15101486 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection of 10 milliliters of lidocaine around the drain tube during removal
Number of subjects: 2
Study 15101486 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 2
Study 11794171 — intervention group
Group type: EXPERIMENTAL
Intervention: Sperm concentration < 13.5 x 10(6) per milliliter; motility < 32%; morphology < 9%
Number of subjects: 1461
Study 11794171 — intervention group
Group type: EXPERIMENTAL
Intervention: Sperm concentration > 48.0 x 10(6) per milliliter; motility > 63%; morphology > 12%
Number of subjects: 1461
Study 11794171 — intervention group
Group type: EXPERIMENTAL
Intervention: Percentage of sperm with normal morphologic features
Number of subjects: 1461
Study 11794171 — intervention group
Group type: EXPERIMENTAL
Intervention: Sperm measurements overall
Number of subjects: 1461
Study 9575014 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 118
Study 9575014 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 118
Study 9575014 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine and Placebo
Number of subjects: 118
Study 7512583 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical retinoid AGN 190168
Number of subjects: 9
Study 7512583 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 9
Study 3351688 — intervention group
Group type: EXPERIMENTAL
Intervention: Tracheal suctioning under direct vision at birth (group I)
Number of subjects: 572
Study 3351688 — intervention group
Group type: COMPARATOR
Intervention: No tracheal suctioning (group II)
Number of subjects: 572
Study 31520370 — intervention group
Group type: EXPERIMENTAL
Intervention: Concomitant therapy (pantoprazole 80 mg, amoxicillin 2000 mg, clarithromycin 1000 mg, and metronidazole 1000 mg daily in divided doses for 14 days)
Number of subjects: 0
Study 31520370 — intervention group
Group type: COMPARATOR
Intervention: Triple therapy (pantoprazole 80 mg, amoxicillin 2000 mg, and clarithromycin 1000 mg daily in divided doses for 14 days)
Number of subjects: 0
Study 29114833 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen (400 mg) and acetaminophen (1000 mg)
Number of subjects: 416
Study 29114833 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxycodone (5 mg) and acetaminophen (325 mg)
Number of subjects: 416
Study 29114833 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocodone (5 mg) and acetaminophen (300 mg)
Number of subjects: 416
Study 29114833 — intervention group
Group type: EXPERIMENTAL
Intervention: Codeine (30 mg) and acetaminophen (300 mg)
Number of subjects: 416
Study 29114833 — intervention group
Group type: COMPARATOR
Intervention: Comparison of oxycodone and acetaminophen vs hydrocodone and acetaminophen
Number of subjects: 416
Study 25628280 — intervention group
Group type: EXPERIMENTAL
Intervention: Cementless Oxford UKA
Number of subjects: 43
Study 25628280 — intervention group
Group type: COMPARATOR
Intervention: Cemented Oxford UKA
Number of subjects: 43
Study 23711446 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic Interval Training (AIT) - 12-week program, 3 sessions per week at 85-90% of peakVO2 and 90-95% of peak heart rate
Number of subjects: 200
Study 23711446 — intervention group
Group type: COMPARATOR
Intervention: Moderate Continuous Training (MCT) - 12-week program, 3 sessions per week at 60-70% of peakVO2 and 65-75% of peak heart rate
Number of subjects: 200
Study 20933047 — intervention group
Group type: EXPERIMENTAL
Intervention: One-step self-etch adhesive (Xeno III; Dentsply/DeTrey)
Number of subjects: 78
Study 20933047 — intervention group
Group type: COMPARATOR
Intervention: Two-step etch-and-rinse adhesive (Exite; Ivoclar Vivadent)
Number of subjects: 78
Study 20933047 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall comparison of annual failure rates
Number of subjects: 78
Study 19213790 — intervention group
Group type: EXPERIMENTAL
Intervention: High microvessel density (MVD) in multimodality-treated stage IIIA patients receiving tumor resection with negative margins (R0)
Number of subjects: 142
Study 19213790 — intervention group
Group type: EXPERIMENTAL
Intervention: Low microvessel density (MVD) in multimodality-treated stage IIIA patients receiving tumor resection with negative margins (R0)
Number of subjects: 142
Study 19213790 — intervention group
Group type: EXPERIMENTAL
Intervention: Stage IIIA patients
Number of subjects: 142
Study 19213790 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenocarcinoma subtype
Number of subjects: 142
Study 16933146 — intervention group
Group type: EXPERIMENTAL
Intervention: Training on work readiness program (3-week intensive training)
Number of subjects: 64
Study 16933146 — intervention group
Group type: COMPARATOR
Intervention: Advice on job placement by social workers (Control group)
Number of subjects: 64
Study 15507095 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous immunotherapy (SIT) with tree pollen (birch)
Number of subjects: 27
Study 15507095 — intervention group
Group type: COMPARATOR
Intervention: No intervention (Control group)
Number of subjects: 27
Study 11698325 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypercapnia (PaCO(2)=44 mmHg)
Number of subjects: 21
Study 11698325 — intervention group
Group type: COMPARATOR
Intervention: Normocapnia (PaCO(2)=38 mmHg)
Number of subjects: 21
Study 11698325 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypocapnia (PaCO(2)=30 mmHg)
Number of subjects: 21
Study 9513073 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem, 10 mg, administered continuously
Number of subjects: 160
Study 9513073 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem, 10 mg, administered intermittently (five nights zolpidem, two consecutive nights placebo per week)
Number of subjects: 160
Study 9513073 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo for two nights per week)
Number of subjects: 160
Study 8062354 — intervention group
Group type: EXPERIMENTAL
Intervention: 60-90 mg amitriptylinoxide (AO)
Number of subjects: 197
Study 8062354 — intervention group
Group type: COMPARATOR
Intervention: 50-75 mg amitriptyline (AM)
Number of subjects: 197
Study 8062354 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 197
Study 3123092 — intervention group
Group type: EXPERIMENTAL
Intervention: O-desmethyl encainide (ODE) infusion
Number of subjects: 9
Study 3123092 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-methoxy-O-desmethyl encainide (3MODE) infusion
Number of subjects: 9
Study 3123092 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 9
Study 3123092 — intervention group
Group type: COMPARATOR
Intervention: Withdrawal of encainide therapy
Number of subjects: 9
Study 3123092 — intervention group
Group type: EXPERIMENTAL
Intervention: ODE infusion
Number of subjects: 9
Study 3123092 — intervention group
Group type: EXPERIMENTAL
Intervention: 3MODE infusion
Number of subjects: 9
Study 31561322 — intervention group
Group type: EXPERIMENTAL
Intervention: Ankylosing spondylitis group (AS)
Number of subjects: 30
Study 31561322 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-AS)
Number of subjects: 30
Study 31976311 — intervention group
Group type: EXPERIMENTAL
Intervention: FMT
Number of subjects: 21
Study 31976311 — intervention group
Group type: EXPERIMENTAL
Intervention: FMT-L
Number of subjects: 21
Study 29066126 — intervention group
Group type: EXPERIMENTAL
Intervention: TRO‐CTA at 100kVp using SAFIRE
Number of subjects: 147
Study 29066126 — intervention group
Group type: COMPARATOR
Intervention: TRO‐CTA at 120kVp using FBP
Number of subjects: 147
Study 26212849 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac
Number of subjects: 104
Study 26212849 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol
Number of subjects: 104
Study 23042922 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose gadobenate dimeglumine
Number of subjects: 46
Study 23042922 — intervention group
Group type: COMPARATOR
Intervention: Double-dose gadopentetate dimeglumine
Number of subjects: 46
Study 21796674 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive character evidence for Black defendants
Number of subjects: 206
Study 21796674 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative character evidence for White defendants
Number of subjects: 206
Study 21796674 — intervention group
Group type: EXPERIMENTAL
Intervention: Character evidence inconsistent with racial stereotypes
Number of subjects: 206
Study 21796674 — intervention group
Group type: COMPARATOR
Intervention: Race of the character witness
Number of subjects: 206
Study 19815913 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxifloxacin (400 mg once daily for 14 days)
Number of subjects: 434
Study 19815913 — intervention group
Group type: COMPARATOR
Intervention: Comparator (doxycycline 100 mg twice daily + metronidazole 400 mg three times daily for 14 days + single 500 mg ciprofloxacin dose)
Number of subjects: 434
Study 19815913 — intervention group
Group type: COMPARATOR
Intervention: Comparator (doxycycline + metronidazole + ciprofloxacin)
Number of subjects: 434
Study 16500319 — intervention group
Group type: EXPERIMENTAL
Intervention: Detailed blastocyst grading system
Number of subjects: 0
Study 16500319 — intervention group
Group type: COMPARATOR
Intervention: Standard blastocyst grading system
Number of subjects: 0
Study 15522045 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart rate variability measures using three commercially available analysers under three conditions: lying supine, standing, lying supine with controlled breathing
Number of subjects: 29
Study 15522045 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart rate variability measures using three commercially available analysers
Number of subjects: 29
Study 12602538 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (T2DA)
Number of subjects: 25
Study 12602538 — intervention group
Group type: COMPARATOR
Intervention: Placebo (T2Dp)
Number of subjects: 25
Study 11077317 — intervention group
Group type: EXPERIMENTAL
Intervention: ppWhipple
Number of subjects: 77
Study 11077317 — intervention group
Group type: COMPARATOR
Intervention: cWhipple
Number of subjects: 77
Study 11077317 — intervention group
Group type: COMPARATOR
Intervention: cWhipple and ppWhipple
Number of subjects: 77
Study 8813038 — intervention group
Group type: COMPARATOR
Intervention: Zidovudine alone (600 mg)
Number of subjects: 2467
Study 8813038 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine plus didanosine (600 mg + 400 mg)
Number of subjects: 2467
Study 8813038 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine plus zalcitabine (600 mg + 2.25 mg)
Number of subjects: 2467
Study 8813038 — intervention group
Group type: EXPERIMENTAL
Intervention: Didanosine alone (400 mg)
Number of subjects: 2467
Study 8813038 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine plus didanosine
Number of subjects: 2467
Study 8813038 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine plus zalcitabine
Number of subjects: 2467
Study 8813038 — intervention group
Group type: EXPERIMENTAL
Intervention: Didanosine alone
Number of subjects: 2467
Study 1363986 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfasalazine, daily dosage of 2 g
Number of subjects: 150
Study 2861846 — intervention group
Group type: EXPERIMENTAL
Intervention: Desensitization
Number of subjects: 0
Study 2861846 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 3591726 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A capsule (200,000 IU)
Number of subjects: 19396
Study 3591726 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonrecipients
Number of subjects: 19396
Study 3591726 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 19396
Study 30239495 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-min walk test (6MWT)
Number of subjects: 187
Study 30239495 — intervention group
Group type: EXPERIMENTAL
Intervention: UNCCRI treadmill protocol
Number of subjects: 187
Study 30239495 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between UNCCRI treadmill protocol and 6MWT
Number of subjects: 187
Study 28751299 — intervention group
Group type: EXPERIMENTAL
Intervention: E‐health4Uth Healthy Toddler intervention (Web‐based personalized advice and face-to-face counseling during well-child visits)
Number of subjects: 2102
Study 28751299 — intervention group
Group type: EXPERIMENTAL
Intervention: E‐health4Uth Healthy Toddler intervention
Number of subjects: 2102
Study 28751299 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 2102
Study 25850817 — intervention group
Group type: EXPERIMENTAL
Intervention: Anteroposterior view
Number of subjects: 201
Study 25850817 — intervention group
Group type: COMPARATOR
Intervention: Oblique view
Number of subjects: 201
Study 25850817 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (where intravascular injections did not occur)
Number of subjects: 201
Study 23122889 — intervention group
Group type: EXPERIMENTAL
Intervention: Definite ACS
Number of subjects: 16618
Study 23122889 — intervention group
Group type: COMPARATOR
Intervention: Possible ACS
Number of subjects: 16618
Study 21810938 — intervention group
Group type: EXPERIMENTAL
Intervention: Prilocaine 0.1%
Number of subjects: 90
Study 21810938 — intervention group
Group type: EXPERIMENTAL
Intervention: Prilocaine 0.2%
Number of subjects: 90
Study 19542686 — intervention group
Group type: EXPERIMENTAL
Intervention: Low socioeconomic status (education)
Number of subjects: 200
Study 19542686 — intervention group
Group type: EXPERIMENTAL
Intervention: Low socioeconomic status (income)
Number of subjects: 200
Study 19542686 — intervention group
Group type: EXPERIMENTAL
Intervention: History of hypertension
Number of subjects: 200
Study 19542686 — intervention group
Group type: EXPERIMENTAL
Intervention: History of diabetes
Number of subjects: 200
Study 19542686 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular intake of folk remedies or over-the-counter Chinese herbs
Number of subjects: 200
Study 19542686 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular intake of multivitamin supplement 5 years before diagnosis
Number of subjects: 200
Study 16410483 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (dalteparin; 100 IU/kg BID)
Number of subjects: 431
Study 16410483 — intervention group
Group type: COMPARATOR
Intervention: Aspirin (160 mg per day)
Number of subjects: 431
Study 15052247 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-dimensional gated SPECT analysis (SPECTEF)
Number of subjects: 136
Study 15052247 — intervention group
Group type: COMPARATOR
Intervention: 3-dimensional QGS
Number of subjects: 136
Study 15052247 — intervention group
Group type: COMPARATOR
Intervention: 3-dimensional p-FAST
Number of subjects: 136
Study 11314826 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.0 grams of MgSO4
Number of subjects: 42
Study 11314826 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 9440362 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal onset principle (e.g., MAR-KET)
Number of subjects: 0
Study 9440362 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress principle (e.g., MARK-ET)
Number of subjects: 0
Study 7943523 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical examination by orthopaedic surgeons
Number of subjects: 39
Study 7943523 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical examination for detecting posterior cruciate ligament tear
Number of subjects: 39
Study 7943523 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical examination for grade II and III posterior laxity
Number of subjects: 39
Study 7943523 — intervention group
Group type: EXPERIMENTAL
Intervention: Agreement on the grade of posterior cruciate ligament tear
Number of subjects: 39
Study 7943523 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior drawer test
Number of subjects: 39
Study 3065687 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN alpha‐2b at 4 x 10(6) U/m2
Number of subjects: 34
Study 3065687 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN alpha‐2b at 2 x 10(6) U/m2
Number of subjects: 34
Study 3065687 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN alpha‐2b at 1 x 10(6) U/m2
Number of subjects: 34
Study 3065687 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN alpha‐2b at 1 x 10(6) U twice a week (maintenance therapy)
Number of subjects: 34
Study 3065687 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN alpha‐2b at 2 x 10(6) U once weekly (maintenance therapy)
Number of subjects: 34
Study 31887617 — intervention group
Group type: EXPERIMENTAL
Intervention: Pomegranate juice and tablets
Number of subjects: 171
Study 31887617 — intervention group
Group type: COMPARATOR
Intervention: Placebo-matching juice and tablets
Number of subjects: 171
Study 31192928 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive nursing intervention
Number of subjects: 300
Study 31192928 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing
Number of subjects: 300
Study 29178917 — intervention group
Group type: EXPERIMENTAL
Intervention: Surface electromyography (EMG)‐triggered electrical stimulation for eight weeks
Number of subjects: 80
Study 29178917 — intervention group
Group type: COMPARATOR
Intervention: Control group (no additional treatment)
Number of subjects: 80
Study 25186211 — intervention group
Group type: EXPERIMENTAL
Intervention: Testimony of a breast cancer survivor (TE group)
Number of subjects: 158
Study 25186211 — intervention group
Group type: EXPERIMENTAL
Intervention: Content-equivalent message composed of expert recommendations (RE group)
Number of subjects: 158
Study 25186211 — intervention group
Group type: COMPARATOR
Intervention: No message (control group)
Number of subjects: 158
Study 23457383 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab (TCZ)
Number of subjects: 4211
Study 21198431 — intervention group
Group type: EXPERIMENTAL
Intervention: Lopinavir/ritonavir (LPV/r) monotherapy
Number of subjects: 136
Study 21198431 — intervention group
Group type: COMPARATOR
Intervention: Lopinavir/ritonavir (LPV/r) + zidovudine (ZDV) + lamivudine (3TC) triple therapy
Number of subjects: 136
Study 21198431 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 136
Study 19399311 — intervention group
Group type: EXPERIMENTAL
Intervention: Condom use at first sexual intercourse
Number of subjects: 214
Study 19399311 — intervention group
Group type: EXPERIMENTAL
Intervention: Delay in sexual debut
Number of subjects: 214
Study 19399311 — intervention group
Group type: EXPERIMENTAL
Intervention: Condom use at first sex
Number of subjects: 214
Study 19399311 — intervention group
Group type: EXPERIMENTAL
Intervention: General condom use ('most or all the time')
Number of subjects: 214
Study 16796137 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled mild hypothermia
Number of subjects: 89
Study 16796137 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 89
Study 12763982 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg (group A)
Number of subjects: 219
Study 12763982 — intervention group
Group type: COMPARATOR
Intervention: Helicobacter pylori test and treat (group B)
Number of subjects: 219
Study 11785865 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication trolley at the patient's bedside
Number of subjects: 340
Study 11785865 — intervention group
Group type: COMPARATOR
Intervention: Ward bay workstation outside the patients' rooms
Number of subjects: 340
Study 9220221 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin
Number of subjects: 299
Study 9220221 — intervention group
Group type: COMPARATOR
Intervention: Lovastatin
Number of subjects: 299
Study 9220221 — intervention group
Group type: COMPARATOR
Intervention: Pravastatin
Number of subjects: 299